Before the science in general (688526.SH) is planning to sign a cooperation and research and development agreement with Huazhong Agricultural University.

Zhitan Finance and Economics APP news, Keqian Biology (688526.SH) announced that, in order to enhance the company's market competitiveness and accelerate the company's development in the bioproduct industry, thus better enhancing the company's brand influence and core competitive strength, the company has successfully negotiated with Huazhong Agricultural University and obtained cooperation in the research and development of the "Porcine Infectious Pleuropneumonia-Streptococcus-Salmonella" trivalent inactivated vaccine, and the "Porcine Circovirus Disease, Glsser's Disease, Streptococcus, Mycoplasma Pneumonia" quadrivalent subunit vaccine, and now plans to sign a joint cooperation agreement with Huazhong Agricultural University for the above two projects. Specifically, the company plans to pay a fee of 2 million RMB to Huazhong Agricultural University for the "Porcine Infectious Pleuropneumonia-Streptococcus-Salmonella" trivalent inactivated vaccine project, and 2 million RMB for the "Porcine Circovirus Disease, Glsser's Disease, Streptococcus, Mycoplasma Pneumonia" quadrivalent subunit vaccine project, totaling 4 million RMB for both projects to Huazhong Agricultural University.